Author:
Kwong Ann D.,Perni Robert B.,Graham Camilla S.
Publisher
Springer International Publishing
Reference59 articles.
1. Houghton M (2009) The long and winding road leading to the identification of the hepatitis C virus. J Hepatol 51(5):939–948
2. Lindenbach BD, Rice CM (2005) Unravelling hepatitis C virus replication: from genome to function. Nature 436:933–938
3. Lohmann V, Korner F, Koch J-O, Herian U, Theilmann L, Bartenschlager R (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110–113
4. Gao M, Nettles RE, Belema M, Snyder LB, Nguyen VN, Fridell RA, Serrano-Wu MH, Langley DR, Sun JH, O’Boyle 2nd DR, Lemm JA, Wang C, Knipe JO, Chien C, Colonno RJ, Grasela DM, Meanwell NA, Hamann LG (2010) Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature 465(7294):96–100
5. Pyenson B, Fitch K, Iwasaki K (2009) Consequences of hepatitis C virus (HCV): costs of a baby boomer epidemic of liver disease. Milliman Inc., New York. This report was commissioned by Vertex Pharmaceuticals, Inc
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Curing Hepatitis C with Direct‐Acting Antiviral Therapy;New Drug Development for Known and Emerging Viruses;2021-12-03